Therapeutic Drug Monitoring Global Market Report 2023: Growing Need for Drug Profiling in Various Medications Boosts Sector

News provided by

Jan 11, 2023, 11:00 ET

DUBLIN, Jan. 11, 2023 /PRNewswire/ -- The "Therapeutic Drug Monitoring Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028: Segmented By Technology, By Drug Class, By Active Ingredient, By End-User, By Product, By Region, Forecast & Opportunities, 2028" report has been added to ResearchAndMarkets.com's offering.

Global therapeutic drug monitoring market is expected to grow at a steady rate during the forecast period, 2024-2028. The growing need of drug profiling for various medications such as anti-epileptics, immunosuppressants, and antibiotics is the major factor for the growth of therapeutic drug monitoring market. TDM or therapeutic drug monitoring is the primary diagnostic tool that is used to deliver an optimized dose of the drugs to define drug concentration range in blood or plasma.

Therapeutic drug monitoring applications include the diagnosis of toxicity and identification and subsequent tailoring of optimal drug dose. Therapeutic drug monitoring also helps in diagnosing the cause of failed therapy outcomes and it can refine patient care by adjusting the drug dosage for better outcomes.

The other factors supporting the growth of the therapeutic drug monitoring market include increasing demand for genetic testing, increased government and private sector participation in therapeutic drug monitoring market and rise in drug profiling. Besides, the rising number of organ transplant procedures and the use of TDM in traditional anticancer therapies are expected to augment the growth of the market.

The global therapeutic drug monitoring market is segmented into technology, drug class, active ingredient, end user, product, company and region. Based on technology, immunoassays are expected to be the dominant segment in the forecast period. Immunoassays are easy to perform and do not require specialized training. Based on drug class, antiepileptic drugs are expected to be the dominant segment in the forecast period. These are most frequently monitored class of drugs due to their narrow therapeutic range and challenging pharmacokinetics.

Regionally, North America is expected to dominate the market in the forecast period. High rate of organ transplantation and gradual adoption of metabolite measuring procedures is the major driving factor for the growth of TDM market in the region. Asia Pacific is the second largest region which is expected to dominate the market share in the forecast period. The continuous efforts of government to provide low-cost services with the aim of promoting dosage patterns is the driving factor for growth of TDM market in Asia Pacific.

Report Scope:

Global Therapeutic Drug Monitoring Market, By Technology:

Immunoassays
Proteomic Technologies

Global Therapeutic Drug Monitoring Market, By Drug Class:

Antiarrhythmic Drugs
Immunosuppressants
Antiepileptic Drugs
Others

Global Therapeutic Drug Monitoring Market, By Active Ingredient:

Amikacin
Caffeine
Carbamazepine
Cyclosporine
Digitoxin
Digoxin
Disopyramide
Ethosuxamide
Gentamicin
Lidocaine
Lithium
Mithotrexate
NAPA
Phenobarbital
Quinidine
Sirolimus
Tacrolimus
Vancomycin
Others

Global Therapeutic Drug Monitoring Market, By End User:

Hospitals
Diagnostic Centers
Others

Global Therapeutic Drug Monitoring Market, By Product:

Immunoassay Equipment
Reagents
Other Consumables

Key Topics Covered:

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Voice of Customer

5. Global Therapeutic Drug Monitoring Market Outlook

6. Asia-Pacific Therapeutic Drug Monitoring Market Outlook

7. Europe Therapeutic Drug Monitoring Market Outlook

8. North America Therapeutic Drug Monitoring Market Outlook

9. South America Therapeutic Drug Monitoring Market Outlook

10. Middle East and Africa Therapeutic Drug Monitoring Market Outlook

11. Market Dynamics

12. Market Trends & Developments

13. Competitive Landscape

14. Strategic Recommendations

Companies Mentioned

Biognosys AG
Siemens Healthineers Inc.
Bio-Rad Laboratories, Inc.
Danaher Corporation
Thermo Fisher Scientific Inc.
F Hoffmann-La Roche Ltd.
BUHLMANN Laboratories AG
Laboratory Corporation of America Holdings
Randox Laboratories Limited
Sekisui Medical Co

For more information about this report visit https://www.researchandmarkets.com/r/bznnvg

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets